Government Initiatives and Funding: The Regulatory Push Accelerating the Development of Novel Agents in the Depression Market Pipeline.
The complexity and vast societal cost associated with untreated depression have prompted governments and international health organizations worldwide to significantly increase their commitment to mental health infrastructure and research. These government initiatives, often expressed through focused national health policies, substantial funding increases for R&D, and regulatory incentives,...
0 Commentarios 0 Acciones 790 Views 0 Vista previa